Drugs that contain Dacomitinib

1. Drug name - VIZIMPRO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7772243 PFIZER 4-phenylamino-quinazolin-6-yl-amides
Aug, 2028

(5 years from now)

CN1972688A PFIZER 4-Phenylamino-Quinazolin-6-Yl-Amides Compounds
Apr, 2025

(2 years from now)

CN1972688B PFIZER 4-Anilino-Quinazoline-6-Yl-Amide Compound
Apr, 2025

(2 years from now)

IN244837B PFIZER 4-Phenylamino-Quinazolin-6-Yl-Amides And A Pharmaceutical Composition Comprising The Same
Apr, 2025

(2 years from now)

IN200606238P1 PFIZER 4-Phenylamino-Quinazolin-6-Yl-Amides
Apr, 2025

(2 years from now)

EP1746999B1 PFIZER 4-Phenylamino-Quinazolin-6-Yl-Amides
Apr, 2025

(2 years from now)

EP1746999A1 PFIZER 4-Phenylamino-Quinazolin-6-Yl-Amides
Apr, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8623883 PFIZER 4-phenylamino-quinazolin-6-yl-amides May, 2025

(2 years from now)

Treatment: First-line treatment of metastatic non small-cell lung cancer (nsclc) with egfr exon 19 deletions or exon 21 (l858r) substitution mutations as detected by an fda-approved test

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
15MG TABLET;ORAL Prescription
30MG TABLET;ORAL Prescription
45MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.